News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
News
ASX Small Cap Lunch Wrap: Who’s tapping into strategic reserves today?
News
10 at 10: Investors in these ASX stocks can see light at the end of the tunnel this morning
News
Weekly Small Cap and IPO Wrap: How did this week’s five IPOs perform?
News
Market Highlights and 5 ASX Small Caps to watch on Friday
News
Closing Bell: One biotech more than doubles, another drops 30pc on debut
News
ASX Small Cap Lunch Wrap: Who’s not getting what they paid for today?
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
News
10 at 10: These ASX stocks are the most imposing this morning
Health & Biotech
AstraZeneca’s COVID-19 fight hits the skids; ASX small cap Biotron says ‘We’re on track’
Health & Biotech
Pharmaxis dealt another blow as partner backs out of second drug development
News
10 at 10: These ASX stocks are leading the rally this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Aussie biotechs join crusade for COVID-19 cure
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
Experts